CAMP4 Therapeutics Corp. (CAMP)
4.30
-0.03
(-0.69%)
USD |
NASDAQ |
Nov 11, 12:10
CAMP4 Therapeutics Market Cap : 269.84M for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 271.73M |
| November 09, 2026 | 294.32M |
| November 06, 2026 | 254.78M |
| November 05, 2026 | 233.45M |
| November 04, 2026 | 234.70M |
| November 03, 2026 | 240.35M |
| November 02, 2026 | 196.02M |
| October 30, 2026 | 205.63M |
| October 29, 2026 | 202.52M |
| October 28, 2026 | 189.53M |
| October 27, 2026 | 189.53M |
| October 26, 2026 | 166.69M |
| October 23, 2026 | 171.36M |
| October 22, 2026 | 176.03M |
| October 21, 2026 | 170.84M |
| October 20, 2026 | 164.09M |
| October 19, 2026 | 163.05M |
| October 16, 2026 | 164.61M |
| October 15, 2026 | 179.15M |
| October 14, 2026 | 178.11M |
| October 13, 2026 | 178.11M |
| October 12, 2026 | 190.05M |
| October 09, 2026 | 195.76M |
| October 08, 2026 | 192.13M |
| October 07, 2026 | 199.40M |
| Date | Value |
|---|---|
| October 06, 2026 | 205.63M |
| October 05, 2026 | 208.23M |
| October 02, 2026 | 207.71M |
| October 01, 2026 | 199.40M |
| September 30, 2026 | 209.79M |
| September 29, 2026 | 203.03M |
| September 28, 2026 | 199.92M |
| September 25, 2026 | 203.55M |
| September 24, 2026 | 199.40M |
| September 23, 2026 | 193.17M |
| September 22, 2026 | 215.50M |
| September 21, 2026 | 216.54M |
| September 18, 2026 | 220.17M |
| September 17, 2026 | 209.27M |
| September 16, 2026 | 200.44M |
| September 15, 2026 | 217.57M |
| September 14, 2026 | 220.69M |
| September 11, 2026 | 220.69M |
| September 10, 2026 | 225.36M |
| September 09, 2026 | 224.84M |
| September 08, 2026 | 228.48M |
| September 04, 2026 | 229.00M |
| September 03, 2026 | 233.15M |
| September 02, 2026 | 197.32M |
| September 01, 2026 | 196.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.183B |
| Alnylam Pharmaceuticals, Inc. | 20.92B |
| Anika Therapeutics, Inc. | 185.64M |
| Savara, Inc. | 1.043B |
| Vericel Corp. | 2.974B |
Market Cap Related Metrics
| PS Ratio | 49.85 |
| Price to Book Value | 2.520 |
| Price | 4.30 |
| Earnings Yield | -47.40% |